Simplex Trading
PYXS icon

Simplex Trading’s Pyxis Oncology PYXS Stock Holding History

Simplex Trading’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
37,902
+37,649
+14,881% +$72K ﹤0.01% 5384
2026
Q1 		$369 Sell
253
-9,537
-97% -$14.4K ﹤0.01% 8767
2025
Q4 		$11.3K Buy
9,790
+2,357
+32% +$8.31K ﹤0.01% 6915
2025
Q3 		$16K Sell
7,433
-5,182
-41% -$7.46K ﹤0.01% 7548
2025
Q2 		$13K Buy
12,615
+3,810
+43% +$4.29K ﹤0.01% 7124
2025
Q1 		$8K Buy
8,805
+5,459
+163% +$7.28K ﹤0.01% 7258
2024
Q4 		$5K Sell
3,346
-25,124
-88% -$72.5K ﹤0.01% 7646
2024
Q3 		$104K Sell
28,470
-12,286
-30% -$43K ﹤0.01% 5194
2024
Q2 		$134K Buy
+40,756
New +$171K ﹤0.01% 5055
2023
Q4 		– Sell
-1,402
Closed -$2.4K – 9618
2023
Q3 		$2K Sell
1,402
-940
-40% -$2.18K ﹤0.01% 8143
2023
Q2 		$5K Buy
+2,342
New +$7.43K ﹤0.01% 7951

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading's PYXS Position: Q2 2026 in Review

Simplex Trading increased its Pyxis Oncology (PYXS) stake by 14,881% in Q2 2026, buying an estimated $72K and bringing the position to 37,902 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #5384.

Simplex Trading first reported a position in PYXS in Q2 2023 and has held it in 11 quarters since. The position peaked at $134K in Q2 2024. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Simplex Trading held 37,902 shares of Pyxis Oncology worth $114K as of Q2 2026.
  • Simplex Trading bought 37,649 Pyxis Oncology shares in Q2 2026, an estimated $72K.
  • Pyxis Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #5384 holding.
  • Simplex Trading first reported a position in Pyxis Oncology in Q2 2023 and has held it in 11 quarters since.
  • Simplex Trading's Pyxis Oncology position peaked at $134K in Q2 2024.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.